[Guillain-Barré syndrome associated with acute hepatitis A-A case report and literature review]

Rinsho Shinkeigaku. 2018 Sep 28;58(9):574-577. doi: 10.5692/clinicalneurol.cn-001165. Epub 2018 Aug 31.
[Article in Japanese]

Abstract

A 44-year-old female developed acute hepatitis A (HA) 5 weeks after ingesting raw oysters. She developed ascending motor weakness, bilateral peripheral facial nerve palsy, and bulbar symptoms. A diagnosis of demyelinating Guillain-Barré syndrome (GBS) was made on the basis of her clinical manifestations and the results of a nerve conduction study. The patient showed improvement following combination treatment with intravascular immunoglobulin and high dose methylprednisolone. No antibodies against specific gangliosides, sulfated glucuronyl paragloboside (SGPG), or sulfatide were detected. HA virus (HAV) RNA was isolated from her serum and its full-length genome sequence was determined. It revealed a homology of 99.9% or more with HAV genotype IA (HAV-IA) of the 2014 outbreak. No mutant virus RNA was detected.

Keywords: HAV genotype IA; bulbar symptoms; demyelinating Guillain-Barré syndrome; facial palsy; hepatitis A.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Disease
  • Adult
  • Female
  • Genotype
  • Guillain-Barre Syndrome / diagnosis
  • Guillain-Barre Syndrome / drug therapy
  • Guillain-Barre Syndrome / etiology*
  • Hepatitis A / complications*
  • Hepatitis A / virology
  • Hepatitis A virus / genetics
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Methylprednisolone / administration & dosage
  • Pulse Therapy, Drug
  • RNA, Viral / genetics

Substances

  • Immunoglobulins, Intravenous
  • RNA, Viral
  • Methylprednisolone